Agree. Ehrlich is a horrible CEO who should have been gone long ago. This “company” is a salesman and a product. The hope is that despite Ehrlich, the drug will be successful. The drug has at least attracted credible parties who are forwarding its banner. The concern though is that history has not favored the Ehrlich hyped pipeline. Will it be different this time around?
News 
Market Data 
Discover 
AI
